A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
about
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).Pemetrexed for primary central nervous system lymphoma in the elderly.Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma.
P2860
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
A phase 1 dose escalation stud ...... oma. The GOELAMS LCP 99 trial.
@ast
A phase 1 dose escalation stud ...... oma. The GOELAMS LCP 99 trial.
@en
type
label
A phase 1 dose escalation stud ...... oma. The GOELAMS LCP 99 trial.
@ast
A phase 1 dose escalation stud ...... oma. The GOELAMS LCP 99 trial.
@en
prefLabel
A phase 1 dose escalation stud ...... oma. The GOELAMS LCP 99 trial.
@ast
A phase 1 dose escalation stud ...... oma. The GOELAMS LCP 99 trial.
@en
P2093
P2860
P356
P1476
A phase 1 dose escalation stud ...... oma. The GOELAMS LCP 99 trial.
@en
P2093
Aline Clavert
Annie Brion
Eric Legouffe
Gaelle Olivier
Isabelle Cumin
Laurence Lacotte-Thierry
Martine Gardembas
Michèle Chabin
Philippe Colombat
Philippe Solal-Celigny
P2860
P304
P356
10.1002/AJH.23812
P577
2014-08-27T00:00:00Z